全文获取类型
收费全文 | 54172篇 |
免费 | 6213篇 |
国内免费 | 369篇 |
专业分类
耳鼻咽喉 | 1194篇 |
儿科学 | 1412篇 |
妇产科学 | 777篇 |
基础医学 | 5753篇 |
口腔科学 | 783篇 |
临床医学 | 6292篇 |
内科学 | 11169篇 |
皮肤病学 | 960篇 |
神经病学 | 5496篇 |
特种医学 | 2268篇 |
外科学 | 11630篇 |
综合类 | 377篇 |
现状与发展 | 3篇 |
一般理论 | 56篇 |
预防医学 | 4367篇 |
眼科学 | 1135篇 |
药学 | 2898篇 |
中国医学 | 35篇 |
肿瘤学 | 4149篇 |
出版年
2023年 | 924篇 |
2022年 | 449篇 |
2021年 | 2137篇 |
2020年 | 1755篇 |
2019年 | 1906篇 |
2018年 | 2692篇 |
2017年 | 2046篇 |
2016年 | 2197篇 |
2015年 | 2285篇 |
2014年 | 3230篇 |
2013年 | 3762篇 |
2012年 | 4665篇 |
2011年 | 4507篇 |
2010年 | 2835篇 |
2009年 | 2687篇 |
2008年 | 3275篇 |
2007年 | 3256篇 |
2006年 | 2866篇 |
2005年 | 2464篇 |
2004年 | 2128篇 |
2003年 | 1784篇 |
2002年 | 1567篇 |
2001年 | 338篇 |
2000年 | 229篇 |
1999年 | 326篇 |
1998年 | 461篇 |
1997年 | 418篇 |
1996年 | 408篇 |
1995年 | 393篇 |
1994年 | 269篇 |
1993年 | 197篇 |
1992年 | 179篇 |
1991年 | 174篇 |
1990年 | 107篇 |
1989年 | 164篇 |
1988年 | 133篇 |
1987年 | 119篇 |
1986年 | 119篇 |
1985年 | 122篇 |
1984年 | 119篇 |
1983年 | 102篇 |
1982年 | 112篇 |
1981年 | 74篇 |
1980年 | 84篇 |
1979年 | 44篇 |
1978年 | 62篇 |
1977年 | 54篇 |
1976年 | 43篇 |
1975年 | 56篇 |
1972年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
4.
5.
Byrne Emma Abel Stephen Yu Alexander Shepard Matthew Karlovits Stephen M. Wegner Rodney E. 《Journal of neuro-oncology》2022,157(1):197-205
Journal of Neuro-Oncology - Adjuvant radiation is often used in patients with low grade gliomas with high-risk characteristics with a recommended dose of 45–54 Gy. We used the... 相似文献
6.
7.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
8.
9.
Matthew C. Phillips Laura Sarff Josh Banerjee Chase Coffey Paul Holtom Steve Meurer Noah Wald-Dickler Brad Spellberg 《Journal of medical virology》2022,94(1):318-326
When hospitals first encountered coronavirus disease 2019 (COVID-19), there was a dearth of therapeutic options and nearly 1 in 3 patients died from the disease. By the summer of 2020, as deaths from the disease declined nationally, multiple single-center studies began to report declining mortality of patients with COVID-19. To evaluate the effect of COVID-19 on hospital-based mortality, we searched the Vizient Clinical Data Base for outcomes data from approximately 600 participating hospitals, including 130 academic medical centers, from January 2017 through December 2020. More than 32 million hospital admissions were included in the analysis. After an initial spike, mortality from COVID-19 declined in all regions of the country to under 10% by June 2020 and remained constant for the remainder of the year. Despite this, inpatient, all-cause mortality has increased since the beginning of the pandemic, even those without respiratory failure. Inpatient mortality has particularly increased in elderly patients and in those requiring intubation for respiratory failure. Since June 2020, COVID-19 kills one in every 10 patients admitted to the hospital with this diagnosis. The addition of this new disease has raised overall hospital mortality especially those who require intubation for respiratory failure. 相似文献
10.
Paul G. Richardson Fredrik Schjesvold Katja Weisel Philippe Moreau Larry D. Anderson Darrell White Paula Rodriguez-Otero Pieter Sonneveld Monika Engelhardt Matthew Jenner Alessandro Corso Jan Dürig Michel Pavic Morten Salomo Meral Beksac Albert Oriol Jindriska Lindsay Anna Marina Liberati Monica Galli Pawel Robak Alessandra Larocca Munci Yagci Filiz Vural Abraham S. Kanate Ruiyun Jiang Lara Grote Teresa Peluso Meletios Dimopoulos 《European journal of haematology》2022,108(1):73-83